Iptacopan Capsules in India

Iptacopan: You know how it works, its dose and dosing instruction but wait, is this information enough to start the therapy. Patients may also look for information about Iptacopan price in India before understanding whether this treatment is appropriate for them.

Who might be the right candidate, who should stay away from this therapy and what are the signals you should keep an eye on? Let’s decode these questions in this article.

Iptacopan (Fabhalta) blocks a protein named factor B to slow down the overactive part of the immune system, protecting the body’s own cells during the attack.

Who should take it?

  • Adults with paroxysmal nocturnal hemoglobinuria (PNH) are the right candidates to take Iptacopan, including patients looking for information about Iptacopan Capsules in India.

Who should avoid it?

  • Patients who are allergic to Iptacopan or any of the ingredients in Fabhalta.
  • Patients who have a serious infection caused by encapsulated bacteria, including Streptococcus pneumoniae, Neisseria meningitidis, or Haemophilus influenzae type B when you are starting Iptacopan treatment.

What should you watch?

  • Iptacopan increases your chance of getting serious infections caused by encapsulated bacteria, including Streptococcus pneumoniae, Neisseria meningitidis, and Haemophilus influenzae type B. These serious infections may quickly become life-threatening or fatal if not recognized and treated early. You must complete or update your vaccinations against these bacteria at least 2 weeks before your first dose of Iptacopan.
  • If you have not completed your vaccinations and Iptacopan must be started right away, you should receive the required vaccinations as soon as possible.
  • If you have not been vaccinated and Iptacopan must be started right away, you should also receive antibiotics to take for as long as your healthcare provider tells you.
  • If you have been vaccinated against these bacteria in the past, you might need additional vaccinations before starting Iptacopan. Your healthcare provider will decide if you need additional vaccinations.
  • Vaccines do not prevent all infections caused by encapsulated bacteria.
  • Call your healthcare provider or get emergency medical care right away if you have any of these signs and symptoms of a serious infection: fever with or without shivers or chills, fever with chest pain, fever with high heart rate, headache and fever, confusion, nausea or vomiting headache and fever, clammy skin, fever and a rash, fever with breathlessness/fast breathing, headache with nausea or vomiting, headache with stiff neck or stiff back, body aches with flu-like symptoms and eyes sensitive to light.
  • Your healthcare provider will give you a Patient Safety Card about the risk of serious infections. Carry it with you at all times during treatment and for 2 weeks after your last dose of Iptacopan. Your risk of serious infections may continue for a few weeks after your last dose of FABHALTA. It is important to show this card to any healthcare provider who treats you. This will help them diagnose and treat you quickly.
  • Iptacopan is only available through a program called the Fabhalta Risk Evaluation and Mitigation Strategy (REMS), and patients researching Iptacopan price in India should also understand the applicable treatment and access requirements. Before you can take Iptacopan, your healthcare provider must:
    1. Enroll in the FABHALTA REMS program
    2. Counsel you about the risk of serious infections caused by certain bacteria
    3. Give you information about the symptoms of serious infections
    4. Make sure that you are vaccinated against serious infections caused by encapsulated bacteria and that you receive antibiotics if you need to start Iptacopan right away and you are not up to date on your vaccinations
    5. Give you a Patient Safety Card about your risk of serious infections, as discussed above.
  • This therapy may increase your cholesterol and triglycerides and your healthcare provider will do blood tests to check them periodically during treatment.

Take a look at the safety aspects of Iptacopan when your doctor prescribes because knowing it creates confidence towards the therapy. Follow 24/7QualityMeds for safety considerations on other rare medications and information about Fabhalta Capsules in India.

Dr. Banisetti Sravya

Linkedin Combining clinical insight with medical writing expertise to create evidence-based healthcare content on chronic illnesses, innovative therapies, and emerging healthcare advances. Translates complex medical research into clear, clinically relevant information for patients, caregivers, and healthcare professionals.